The Central Drugs Standard Control Organization (CDSCO) has issued an alert about the List of Drugs, Medical Devices and Cosmetics declared as Not of Standard Quality/Spurious/Adulterated/Misbranded for the Month of March – 2023.
In this list released by CDSCO, Shockingly there were 48 drugs which are reported to have failed the quality test.
48 drugs include Popular Cardiac Drugs Telmisartan 40 mg and Amlodipine 5 mg Tablets IP (Telma-AM Tablets) from Glenmark, Meswak from Dabur India.
CDSCO warns of 48 commonly used drugs failing quality tests.